BRIEF-QLT says reviewing strategic alternatives

Wed Nov 20, 2013 4:07pm EST
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

Nov 20 (Reuters) - QLT Inc : * Announces oral retinoid program clinical and regulatory update, and review of

strategic alternatives * Says for the review, the board of directors has engaged Credit Suisse to act

as financial advisor * Source text for Eikon * Further company coverage